Telemedicine: Consult from home
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
Calculate it
There, weight-loss coverage held at 36 percent, while diabetes-only coverage rose to 60 percent from 55 percent in 2025, according to the foundation
Ethics declarations Conflict of Interest Binayak Sinha and Samit Ghosal have nothing to declare
BPC-157 therapy may also be considered by individuals participating in wellness or longevity-focused programs who want additional support for recovery, circulation, or general physical resilience